Susquehanna Fundamental Investments’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
28,884
-14,259
| -33% | -$161K | 0.01% | 608 |
|
|
2025
Q1 | $498K | Sell |
43,143
-37,176
| -46% | -$429K | 0.01% | 842 |
|
|
2024
Q4 | $680K | Buy |
+80,319
| New | +$680K | 0.01% | 796 |
|
|
2024
Q2 | $807K | Buy |
68,526
+52,347
| +324% | +$617K | 0.02% | 597 |
|
|
2024
Q1 | $192K | Buy |
+16,179
| New | +$192K | 0.01% | 624 |
|
|
2021
Q4 | – | Sell |
-23,871
| Closed | -$417K | – | 1611 |
|
|
2021
Q3 | $417K | Sell |
23,871
-5,686
| -19% | -$99.3K | 0.01% | 1284 |
|
|
2021
Q2 | $708K | Sell |
29,557
-11,010
| -27% | -$264K | 0.01% | 1019 |
|
|
2021
Q1 | $1.04M | Buy |
40,567
+11,600
| +40% | +$298K | 0.02% | 873 |
|
|
2020
Q4 | $550K | Buy |
+28,967
| New | +$550K | 0.01% | 1066 |
|